China Pharma Holdings Inc. (AMEX: CPHI) stock fell -3.14% on Friday to $0.09 against a previous-day closing price of $0.09. With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.93 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.0980 whereas the lowest price it dropped to was $0.0860. The 52-week range on CPHI shows that it touched its highest point at $2.46 and its lowest point at $0.08 during that stretch. Beta for the stock currently stands at 0.93.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPHI was up-trending over the past week, with a rise of 0.34%, but this was down by -30.33% over a month. Three-month performance dropped to -67.77% while six-month performance fell -71.74%. The stock lost -92.29% in the past year, while it has lost -90.66% so far this year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 29.70%.
Float and Shares Shorts:
At present, 32.95 million CPHI shares are outstanding with a float of 32.43 million shares on hand for trading. On Oct 30, 2023, short shares totaled 43750.0, which was 0.38% higher than short shares on Sep 28, 2023. In addition to Ms. Zhilin Li as the firm’s President, CEO, Chairman & Interim CFO, Ms. Huang Na C.F.A. serves as its BOD Secretary & IR Manager.
Through their ownership of 2.45% of CPHI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 0.61% of CPHI, in contrast to 0.05% held by mutual funds. As the largest shareholder in CPHI with 0.30% of the stake, Millennium Management LLC holds 96,783 shares worth 96,783. A second-largest stockholder of CPHI, Two Sigma Securities LLC, holds 60,844 shares, controlling over 0.19% of the firm’s shares. Renaissance Technologies LLC is the third largest shareholder in CPHI, holding 30,930 shares or 0.10% stake. With a 0.05% stake in CPHI, the Bridgeway Ultra Small Company Mar is the largest stakeholder. A total of 14,500 shares are owned by the mutual fund manager.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CPHI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CPHI analysts setting a high price target of $45.00 and a low target of $45.00, the average target price over the next 12 months is $45.00. Based on these targets, CPHI could surge 49900.0% to reach the target high and rise by 49900.0% to reach the target low. Reaching the average price target will result in a growth of 49900.0% from current levels.
Summary of Insider Activity:
Insiders traded CPHI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.